| Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis T Xie, D Wei, M Liu, AC Gao, F Ali-Osman, R Sawaya, S Huang Oncogene 23 (20), 3550-3560, 2004 | 728 | 2004 |
| Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis D Wei, X Le, L Zheng, L Wang, JA Frey, AC Gao, Z Peng, S Huang, ... Oncogene 22 (3), 319-329, 2003 | 699 | 2003 |
| Mechanisms of resistance in castration-resistant prostate cancer (CRPC) T Chandrasekar, JC Yang, AC Gao, CP Evans Translational andrology and urology 4 (3), 365, 2015 | 618 | 2015 |
| Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ... JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017 | 391 | 2017 |
| Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer C Liu, W Lou, Y Zhu, N Nadiminty, CT Schwartz, CP Evans, AC Gao Clinical cancer research 20 (12), 3198-3210, 2014 | 351 | 2014 |
| Interleukin‐6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway W Lou, Z Ni, K Dyer, DJ Tweardy, AC Gao The prostate 42 (3), 239-242, 2000 | 345 | 2000 |
| CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13 AC Gao, W Lou, JT Dong, JT Isaacs Cancer research 57 (5), 846-849, 1997 | 309 | 1997 |
| Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells Z Ni, W Lou, ES Leman, AC Gao Cancer Research 60 (5), 1225-1228, 2000 | 288 | 2000 |
| Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells SO Lee, W Lou, M Hou, F de Miguel, L Gerber, AC Gao Clinical Cancer Research 9 (1), 370-376, 2003 | 258 | 2003 |
| Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer C Liu, W Lou, Y Zhu, JC Yang, N Nadiminty, NW Gaikwad, CP Evans, ... Cancer research 75 (7), 1413-1422, 2015 | 253 | 2015 |
| NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants N Nadiminty, R Tummala, C Liu, J Yang, W Lou, CP Evans, AC Gao Molecular cancer therapeutics 12 (8), 1629-1637, 2013 | 211 | 2013 |
| MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells N Nadiminty, R Tummala, W Lou, Y Zhu, J Zhang, X Chen, RWV White, ... Journal of Biological Chemistry 287 (2), 1527-1537, 2012 | 207 | 2012 |
| Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model HG Nguyen, JC Yang, HJ Kung, XB Shi, D Tilki, PN Lara, ... Oncogene 33 (36), 4521-4530, 2014 | 202 | 2014 |
| Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer X Sun, HF Frierson, C Chen, C Li, Q Ran, KB Otto, BM Cantarel, ... Nature genetics 37 (4), 407-412, 2005 | 200 | 2005 |
| MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth N Nadiminty, R Tummala, W Lou, Y Zhu, XB Shi, JX Zou, H Chen, J Zhang, ... PloS one 7 (3), e32832, 2012 | 196 | 2012 |
| Stat3 activation in prostatic carcinomas R Dhir, Z Ni, W Lou, F DeMiguel, JR Grandis, AC Gao The Prostate 51 (4), 241-246, 2002 | 194 | 2002 |
| Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop P Yang, L Guo, ZJ Duan, CG Tepper, L Xue, X Chen, HJ Kung, AC Gao, ... Molecular and cellular biology 32 (15), 3121-3131, 2012 | 192 | 2012 |
| Methylation of the CD44 Metastasis Suppressor Gene in Human Prostate Cancer W Lou, D Krill, R Dhir, MJ Becich, JT Dong, HF Frierson Jr, WB Isaacs, ... Cancer research 59 (10), 2329-2331, 1999 | 189 | 1999 |
| Molecular mechanisms of castration-resistant prostate cancer progression SS Dutt, AC Gao Future oncology 5 (9), 1403-1413, 2009 | 185 | 2009 |
| ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer J Wang, JX Zou, X Xue, D Cai, Y Zhang, Z Duan, Q Xiang, JC Yang, ... Nature medicine 22 (5), 488-496, 2016 | 176 | 2016 |
